[Drug therapy of dysmenorrhea].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D001241:Aspirin / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003276:Contraceptives, Oral / Q000627:therapeutic use; D004412:Dysmenorrhea / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D005439:Flufenamic Acid / Q000627:therapeutic use; D006801:Humans; D007052:Ibuprofen / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D008274:Magnesium / Q000627:therapeutic use; D008528:Mefenamic Acid / Q000627:therapeutic use; D008954:Models, Biological; D009288:Naproxen / Q000627:therapeutic use; D011372:Progestins / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D002121:Calcium Channel Blockers; D003276:Contraceptives, Oral; D011372:Progestins; D008528:Mefenamic Acid; D009288:Naproxen; D005439:Flufenamic Acid; D008274:Magnesium; D001241:Aspirin; D007052:Ibuprofen; D007213:Indomethacin
Die medikamentöse Therapie der Dysmenorrhoe.